Cincinnati Dermatological Society Meetings

Wednesday, April 9, 2025, 3:30 PM - 6:15 PM, Closed Session | Contact Coordinator for Special Consideration, Cincinnati, OH

AMA PRA Category 1 Credits™ (2.75 hours), AMA PRA Category 1 Credits™ Designated (2.75 hours)

Cincinnati Dermatological Society Meeting Series

Course Director: Katherine Baquerizo Nole, MD

Conference Coordinator: Carolyn Hunter

Closed to invited guest only. For more information, contact the conference coordinator.

In order to receive credit, you must sign-in at conference.

1. Discuss current evidence/science/research related to skin biology.
2. Discuss conditions that are relatively rare and may not be seen frequently in clinical practice.
3. Integrate histopathologic data in the diagnosis of dermatologic disorders.
4. Describe diagnostic studies in the diagnosis of dermatologic disorders.
5. Demonstrate different approaches to treat dermatologic disorders.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and the Cincinnati Dermatological Society. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.

The University of Cincinnati designates this live activity for a maximum of 2.75 AMA PRA Category 1 Credits™. Physicians should claim only the credits commensurate with the extent of their participation in the activity.

 

COI / Disclosure of Relationships with Ineligible Entities

In accordance with the ACCME Standards for Integrity and Independence Integrity and Independence in Accredited Continuing Education and the University of Cincinnati policy, all faculty, planning committee members, and other individuals, who are in a position to control content, are required to disclose all relationships with ineligible companies* (commercial interests) within the last 24-months. All educational materials are reviewed for fair balance, scientific objectivity, and levels of evidence. The ACCME requires us to disqualify individuals who refuse to provide this information from involvement in the planning and implementation of accredited continuing education, or whose conflicts of interests cannot be mitigated.

*Companies that are ineligible to be accredited in the ACCME System (ineligible companies) are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant relationships have been mitigated. The following disclosures were made:

Planning Committee Members
The following planners have nothing to disclose unless otherwise noted.

Katherine Baquerizo Nole, MD- Course Director
Sub-Investigator-current: Galderma, UCB, Incyte, Castle, Biogen, Celldex
Sub-Investigator-ended relationships/24 months: Trevi Therapeutics (ended 4/2023,) Leo (ended 10/2023) Bayer (ended 3/2024) Cara (ended 3/2024)

Mona Ford, MD- Mona Dermatology

Carolyn Hunter, Conference Coordinator

Paula Klepper, CCPD/CME Program Manager

Mitigation of Relevant Financial Relationships

The University of Cincinnati adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all financial relationships with ineligible entities (commercial interests) over the last 24-months. All relevant relationships have been mitigated prior to the commencement of the activity.

Information regarding the new updated ACCME Standards for Integrity and Independence in Accredited Continuing Education can be found on the ACCME website.

Date	Empty Column	Title
		No activities are currently published for this month.
No upcoming dates have been setup.